Literature DB >> 20389039

New ventures in the genotoxic and cytotoxic effects of macrocyclic lactones, abamectin and ivermectin.

G Molinari1, S Soloneski, M L Larramendy.   

Abstract

Abamectin and Ivermectin are 2 closely related members of the Avermectin family of 16-membered macrocyclic lactones derived from the actinomycete Streptomyces avermectinius which exhibit extraordinary anthelmintic activity. They are used worldwide in veterinary and human medicine as well as in agriculture. In the present review we summarized the results published so far for estimating the genotoxicity and cytotoxicity exerted by both compounds in several cellular systems. Although both compounds do not induce in vitro and in vivo gene mutations in either bacterial or mammalian cells, there is no concrete evidence of a clear clastogenic effect exerted both in vitro and in vivo in mammalian cells. However, reports indicating that both anthelmintic agents are able to induce single DNA-strand breaks in vitro and inhibit cell growth either in vitro or in in vivo bioassays, are scarce. Taking into account the similarity of the genotoxicity and cytotoxicity exerted by both antibiotics, and that only Abamectin has been classified so far as a class II toxicity pesticide by the EPA, the necessity of reconsideration for a further hazard evaluation of Ivermectin by an international regulatory agency(ies) is strongly recommended. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20389039     DOI: 10.1159/000293923

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  10 in total

1.  Sensitivity of Eisenia andrei (Annelida, Oligochaeta) to a commercial formulation of abamectin in avoidance tests with artificial substrate and natural soil under tropical conditions.

Authors:  Maria Edna Tenório Nunes; Evaldo Luiz Gaeta Espíndola
Journal:  Ecotoxicology       Date:  2012-05       Impact factor: 2.823

2.  Larvicidal activity of isolated compound 5-(2,4-dimethylbenzyl) pyrrolidin-2-one from marine Streptomyces VITSVK5 sp. against Rhipicephalus (Boophilus) microplus, Anopheles stephensi, and Culex tritaeniorhynchus.

Authors:  Kumar Saurav; Govindasamy Rajakumar; Krishnan Kannabiran; Abdul Abdul Rahuman; Kanayairam Velayutham; Gandhi Elango; Chinnaperumal Kamaraj; Abdul Abduz Zahir
Journal:  Parasitol Res       Date:  2011-10-19       Impact factor: 2.289

3.  Ivermectin reduces alcohol intake and preference in mice.

Authors:  Megan M Yardley; Letisha Wyatt; Sheraz Khoja; Liana Asatryan; Marcia J Ramaker; Deborah A Finn; Ronald L Alkana; Nhat Huynh; Stan G Louie; Nicos A Petasis; Marco Bortolato; Daryl L Davies
Journal:  Neuropharmacology       Date:  2012-03-23       Impact factor: 5.250

4.  Isolation and characterisation of acaricidal and larvicidal novel compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one from Streptomyces sp. against blood-sucking parasites.

Authors:  Thimiri Lakshmipathi Deepika; Krishnan Kannabiran; Venkatesan Gopiesh Khanna; Govindasamy Rajakumar; Chidambaram Jayaseelan; Thirunavukkarasu Santhoshkumar; Abdul Abdul Rahuman
Journal:  Parasitol Res       Date:  2011-06-23       Impact factor: 2.289

5.  Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder.

Authors:  Megan M Yardley; Nhat Huynh; Kathleen E Rodgers; Ronald L Alkana; Daryl L Davies
Journal:  Alcohol       Date:  2015-05-29       Impact factor: 2.405

Review 6.  Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.

Authors:  Daryl L Davies; Marco Bortolato; Deborah A Finn; Marcia J Ramaker; Segev Barak; Dorit Ron; Jing Liang; Richard W Olsen
Journal:  Alcohol Clin Exp Res       Date:  2012-06-04       Impact factor: 3.455

7.  Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans.

Authors:  Megan M Yardley; Michael Neely; Nhat Huynh; Liana Asatryan; Stan G Louie; Ronald L Alkana; Daryl L Davies
Journal:  Neuroreport       Date:  2014-09-10       Impact factor: 1.837

8.  Repurposing anthelmintic agents to eradicate resistant leukemia.

Authors:  Caterina Mezzatesta; Liridon Abduli; Anna Guinot; Cornelia Eckert; Denis Schewe; Marketa Zaliova; Luciana Vinti; Blerim Marovca; Yi-Chien Tsai; Silvia Jenni; Julia Aguade-Gorgorio; Arend von Stackelberg; Martin Schrappe; Franco Locatelli; Martin Stanulla; Gunnar Cario; Jean-Pierre Bourquin; Beat C Bornhauser
Journal:  Blood Cancer J       Date:  2020-06-26       Impact factor: 11.037

9.  Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway.

Authors:  Ping Zhang; Yang Zhang; Kuikui Liu; Bin Liu; Wenping Xu; Jufang Gao; Lei Ding; Liming Tao
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

10.  Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells.

Authors:  Jingjing Liu; Hongsheng Liang; Chen Chen; Xiaoxing Wang; Faling Qu; Haiyang Wang; Kongbin Yang; Qing Wang; Ning Zhao; Jing Meng; Aili Gao
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.